Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_assertion type Assertion NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_head.
- NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_assertion description "[Moreover, a set of 6 genes comprising ATR, LYK5, MPP2, PIK3CG, PIK4CA, and WNK4 were identified as contributing to both cell proliferation and resistance to cisplatin treatment in medulloblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_provenance.
- NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_assertion evidence source_evidence_literature NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_provenance.
- NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_assertion SIO_000772 21652733 NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_provenance.
- NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_assertion wasDerivedFrom befree-2016 NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_provenance.
- NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_assertion wasGeneratedBy ECO_0000203 NP900248.RAc723rFahY4NZc39KK7vGdMt1H7TnsN4dQ7SL5SBiHvY130_provenance.